Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ferrosoferric Oxide | 12 | 2023 | 39 | 3.360 |
Why?
|
| Magnetic Resonance Imaging | 25 | 2023 | 7717 | 1.700 |
Why?
|
| Positron-Emission Tomography | 13 | 2023 | 2182 | 1.350 |
Why?
|
| Contrast Media | 8 | 2022 | 1474 | 1.150 |
Why?
|
| Cartilage, Articular | 3 | 2022 | 70 | 1.140 |
Why?
|
| Cartilage Diseases | 3 | 2023 | 23 | 1.110 |
Why?
|
| Whole Body Imaging | 6 | 2023 | 114 | 1.020 |
Why?
|
| Fluorodeoxyglucose F18 | 10 | 2023 | 1237 | 0.960 |
Why?
|
| Magnetite Nanoparticles | 3 | 2020 | 50 | 0.920 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2023 | 204 | 0.880 |
Why?
|
| Cell Tracking | 2 | 2023 | 38 | 0.710 |
Why?
|
| Femur Head Necrosis | 1 | 2018 | 11 | 0.660 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2023 | 133 | 0.590 |
Why?
|
| Osteonecrosis | 1 | 2017 | 55 | 0.580 |
Why?
|
| Fractures, Spontaneous | 1 | 2017 | 82 | 0.570 |
Why?
|
| Edema | 2 | 2022 | 265 | 0.570 |
Why?
|
| Multimodal Imaging | 6 | 2020 | 548 | 0.570 |
Why?
|
| Bone Diseases | 1 | 2017 | 140 | 0.560 |
Why?
|
| Swine | 7 | 2023 | 1550 | 0.560 |
Why?
|
| Bone Marrow Diseases | 1 | 2017 | 174 | 0.550 |
Why?
|
| Radiopharmaceuticals | 8 | 2023 | 1308 | 0.540 |
Why?
|
| Swine, Miniature | 4 | 2022 | 67 | 0.490 |
Why?
|
| Osteosarcoma | 1 | 2021 | 920 | 0.480 |
Why?
|
| Brain Diseases | 1 | 2017 | 403 | 0.460 |
Why?
|
| Glucocorticoids | 1 | 2017 | 637 | 0.450 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 1639 | 0.440 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1367 | 0.410 |
Why?
|
| Heart Diseases | 1 | 2017 | 738 | 0.380 |
Why?
|
| Bone Marrow | 2 | 2022 | 2360 | 0.380 |
Why?
|
| Neoplasms | 9 | 2023 | 15180 | 0.340 |
Why?
|
| Nanoparticles | 3 | 2023 | 557 | 0.340 |
Why?
|
| Bone Neoplasms | 4 | 2023 | 2559 | 0.330 |
Why?
|
| Young Adult | 13 | 2023 | 21494 | 0.330 |
Why?
|
| Gadolinium | 2 | 2021 | 165 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2023 | 341 | 0.330 |
Why?
|
| Leukemia | 1 | 2017 | 1633 | 0.320 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 390 | 0.300 |
Why?
|
| Adolescent | 14 | 2023 | 31239 | 0.300 |
Why?
|
| Brain | 1 | 2020 | 4097 | 0.290 |
Why?
|
| Child | 18 | 2023 | 29067 | 0.280 |
Why?
|
| Stem Cells | 3 | 2023 | 1206 | 0.270 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 845 | 0.230 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 4976 | 0.210 |
Why?
|
| Gallium Radioisotopes | 1 | 2022 | 60 | 0.210 |
Why?
|
| Tissue Distribution | 2 | 2021 | 877 | 0.210 |
Why?
|
| Vascular System Injuries | 1 | 2022 | 52 | 0.200 |
Why?
|
| Chondrogenesis | 1 | 2021 | 66 | 0.190 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 130 | 0.190 |
Why?
|
| Staining and Labeling | 2 | 2020 | 427 | 0.190 |
Why?
|
| Pleura | 1 | 2021 | 127 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2023 | 12923 | 0.180 |
Why?
|
| Pediatrics | 2 | 2020 | 1130 | 0.180 |
Why?
|
| Sarcoma | 3 | 2019 | 1725 | 0.180 |
Why?
|
| Brain Chemistry | 1 | 2020 | 145 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2021 | 73 | 0.180 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2023 | 260 | 0.180 |
Why?
|
| Adipose Tissue | 2 | 2022 | 766 | 0.170 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 249 | 0.170 |
Why?
|
| Gadolinium DTPA | 1 | 2019 | 171 | 0.170 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 762 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 52 | 0.160 |
Why?
|
| Bone Regeneration | 1 | 2018 | 30 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2020 | 33028 | 0.160 |
Why?
|
| Iron | 1 | 2021 | 377 | 0.150 |
Why?
|
| Systems Integration | 1 | 2017 | 77 | 0.150 |
Why?
|
| Adult | 11 | 2023 | 78179 | 0.150 |
Why?
|
| Animals | 9 | 2023 | 59489 | 0.150 |
Why?
|
| Femur | 1 | 2017 | 159 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2023 | 4043 | 0.140 |
Why?
|
| Humans | 24 | 2023 | 262248 | 0.130 |
Why?
|
| Allografts | 1 | 2018 | 656 | 0.130 |
Why?
|
| Observer Variation | 1 | 2017 | 671 | 0.130 |
Why?
|
| Male | 12 | 2023 | 123338 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 2804 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14288 | 0.120 |
Why?
|
| Radiography | 1 | 2019 | 1900 | 0.120 |
Why?
|
| Radiology | 1 | 2019 | 434 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2018 | 834 | 0.110 |
Why?
|
| Organ Preservation | 2 | 2011 | 43 | 0.110 |
Why?
|
| Female | 10 | 2022 | 142293 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2022 | 1799 | 0.100 |
Why?
|
| Macrophages | 1 | 2018 | 1313 | 0.100 |
Why?
|
| Receptors, Complement | 1 | 2011 | 48 | 0.100 |
Why?
|
| Brain Death | 1 | 2011 | 53 | 0.090 |
Why?
|
| Cancer Survivors | 1 | 2017 | 649 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2020 | 6104 | 0.090 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 129 | 0.090 |
Why?
|
| Lymphoma | 1 | 2018 | 1471 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2020 | 2969 | 0.080 |
Why?
|
| Cryopreservation | 1 | 2010 | 174 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2023 | 16213 | 0.080 |
Why?
|
| Catheterization | 1 | 2011 | 410 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2021 | 38011 | 0.080 |
Why?
|
| Perfusion | 1 | 2010 | 294 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 6046 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7218 | 0.070 |
Why?
|
| Disease Progression | 1 | 2017 | 6693 | 0.070 |
Why?
|
| Epiphyses | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cartilage | 1 | 2023 | 123 | 0.050 |
Why?
|
| Kidney | 1 | 2011 | 2144 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2023 | 13669 | 0.050 |
Why?
|
| Knee Joint | 1 | 2022 | 170 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 17622 | 0.050 |
Why?
|
| Prognosis | 1 | 2017 | 21737 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2019 | 130 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 112 | 0.040 |
Why?
|
| Hematinics | 1 | 2019 | 110 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2020 | 555 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 625 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 133 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5598 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2017 | 232 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 695 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 1650 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 2041 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 7566 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 862 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2018 | 1382 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4337 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2011 | 410 | 0.020 |
Why?
|
| Complement Activation | 1 | 2011 | 93 | 0.020 |
Why?
|
| Procaine | 1 | 2010 | 8 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2010 | 20 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 55 | 0.020 |
Why?
|
| Mannitol | 1 | 2010 | 54 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 3879 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 3755 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 148 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 124 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 421 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 5055 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 14561 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 719 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13285 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 1247 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 6107 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 2824 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 34393 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 11571 | 0.010 |
Why?
|